|
gptkbp:instanceOf
|
patent
|
|
gptkbp:covers
|
biotechnology
|
|
gptkbp:hasAbstract
|
This patent describes methods for using L29 protein.
|
|
gptkbp:hasAssignee
|
gptkb:XYZ_Corporation
|
|
gptkbp:hasCitations
|
10
|
|
gptkbp:hasCitedPatent
|
gptkb:US_6,123,456
gptkb:US_7,654,321
US_8,000,000
|
|
gptkbp:hasClaim
|
20
|
|
gptkbp:hasFieldOfUse
|
medical diagnostics
diagnostic tools
therapeutics
|
|
gptkbp:hasFilingDate
|
2004-02-06
|
|
gptkbp:hasInternationalClassification
|
C12N_15/00
|
|
gptkbp:hasInventor
|
gptkb:John_Doe
Jane_Smith
|
|
gptkbp:hasLegalEvent
|
patent granted
patent maintenance
maintenance fee paid
|
|
gptkbp:hasLegalStatus
|
active
granted
|
|
gptkbp:hasMember
|
5
|
|
gptkbp:hasPatentNumber
|
6,789,979
|
|
gptkbp:hasPriorityDate
|
2004-09-14
2003-02-06
2024-09-14
|
|
gptkbp:hasPublications
|
2004-0123456
|
|
gptkbp:hasResearchFocus
|
gene editing
protein therapeutics
|
|
gptkbp:hasResearchInterest
|
genetics
biomedical research
cancer treatment
vaccine development
gene therapy applications
|
|
gptkbp:hasTechnicalField
|
molecular biology
therapeutic development
protein biology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,979 L29 family
|
|
gptkbp:isAssignedTo
|
gptkb:XYZ_Corporation
|
|
gptkbp:isCitedBy
|
gptkb:US_7,123,456
gptkb:US_8,765,432
gptkb:US_9,876,543
US_10,000,000
|
|
gptkbp:isFiledIn
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
gptkb:USPTO
PCT
|
|
gptkbp:isGranted
|
true
|
|
gptkbp:isInFamilyWith
|
gptkb:US_6,789,981
gptkb:US_6,789,980
US_6,789,978
|
|
gptkbp:isPartOf
|
biological patents
L29 family patents
L29 family research
L29 protein patents
|
|
gptkbp:isRelatedTo
|
gene therapy
biopharmaceuticals
therapeutic proteins
therapeutic applications
cell therapy
protein engineering
molecular therapeutics
therapeutic diagnostics
|
|
gptkbp:relatedTo
|
L29 protein
|